title: [Use of amiksin in complex therapy of cerebral gliomas].
abstract: Indices were studied for cell-bound immunity during administration of a multimodality therapy treatments with making use of amiksin in patients with glial tumours of the brain IV degree anaplasia. Processes of lymph formation and differentiation of lymphocytes into natural killer cells have been found out to return to normal. No total stimulating action was recorded of the drug that would lead to stimulation of progressive growth of gliomas.
authors.forename: M I
authors.initials: MI
authors.lastname: Lisianyĭ
authors.forename: S A
authors.initials: SA
authors.lastname: Skitiak
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005909:Glioblastoma / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007369:Interferon Inducers / Q000276:immunology / Q000627:therapeutic use*; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013994:Tilorone / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D007369:Interferon Inducers; D013994:Tilorone